PAM
ITCI

Premier Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Premier Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,119
Closed -$377K – 163
2021
Q3 		$377K Sell
10,119
-32,492
-76% -$1.13M 0.05% 127
2021
Q2 		$1.74M Buy
42,611
+30,152
+242% +$1.11M 0.26% 64
2021
Q1 		$423K Sell
12,459
-14,147
-53% -$491K 0.08% 137
2020
Q4 		$846K Sell
26,606
-1,131
-4% -$29.7K 0.17% 82
2020
Q3 		$712K Buy
27,737
+7,023
+34% +$160K 0.18% 70
2020
Q2 		$532K Sell
20,714
-10,840
-34% -$219K 0.18% 71
2020
Q1 		$485K Buy
+31,554
New +$685K 0.2% 70
2019
Q3 		– Sell
-72,758
Closed -$944K – 149
2019
Q2 		$944K Buy
+72,758
New +$933K 0.22% 66
2019
Q1 		– Sell
-63,304
Closed -$721K – 147
2018
Q4 		$721K Buy
+63,304
New +$1.02M 0.19% 78
2018
Q2 		– Sell
-19,088
Closed -$402K – 133
2018
Q1 		$402K Buy
19,088
+2,262
+13% +$44.1K 0.09% 97
2017
Q4 		$244K Sell
16,826
-1,603
-9% -$24.8K 0.05% 115
2017
Q3 		$291K Buy
+18,429
New +$270K 0.07% 105

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Premier Asset Management's ITCI Position: Q4 2021 in Review

Premier Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2021, closing a stake of 10,119 shares — an estimated $377K sold.

Premier Asset Management first reported a position in ITCI in Q3 2017 and held it in 12 quarters. The position peaked at $1.74M in Q2 2021. 208 funds tracked by Wall St. Rank hold ITCI as of Q4 2021.

  • Premier Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2021 after selling out during the quarter.
  • Premier Asset Management sold 10,119 Intra-Cellular Therapies Inc. shares in Q4 2021, an estimated $377K.
  • Premier Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2017 and held it in 12 quarters.
  • Premier Asset Management's Intra-Cellular Therapies Inc. position peaked at $1.74M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2021.

Based on Premier Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.